Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?

Table 1 Evolution of pancreatic cancer staging and workup in the era of coronavirus disease 2019

Component of care	Pre COVID-19	Risk group	Post COVID-19
Multidisciplinary evaluation	Appointments with medical, radiation, surgical oncologists and gastroenterologists	Patients and health care providers	Tele-medicine
Tumor board Conference	On-site meetings	Excess contact of involved caregivers	Virtual meeting
Diagnostic Methods	Sectional imaging, endoscopic interventions and laboratory visits	Excess contact of health care providers and patients	Reduce diagnostic interventions to minimum needed, avoidance of endoscopic biopsy
Surgical staging	Pre-resection laparoscopic staging	Patients, surgeons and operative room staff	Substitute by imaging
Genetic evaluation	Inperson counseling/testing	Patient, family and counselor	Tele-counseling

COVID-19: Coronavirus disease 2019.